Stockreport

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize dr [Read more]